CN Stock MarketDetailed Quotes

Tonghua Dongbao Pharmaceutical (600867)

Watchlist
  • 8.43
  • +0.02+0.24%
Not Open Jan 7 15:00 CST
16.51BMarket Cap13.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tonghua Dongbao Pharmaceutical (600867) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
生物制品(原料药及制剂产品)1.24B90.29%
注射用笔、血糖试纸等医疗器械83.36M6.07%
中成药和化药30.73M2.24%
Other business17.46M1.27%
丽景花园小区房产租售1.86M0.14%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical industry1.35B98.59%
Other business17.46M1.27%
Real estate industry1.86M0.14%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic1.26B92.00%
Abroad109.86M8.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.34%
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +9.84%
4
JD HEALTH
06618
+8.85%
5
ALI HEALTH
00241
+8.61%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +5.95%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.39%
4
Block
XYZ
+2.39%
5
Microsoft
MSFT
+2.09%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -